06/12/2026
Pre-shipment photo of our modular CIP/SIP Unit [CSW-50], specifically designed for in-situ cleaning and sterilization of process equipment used in parenteral drug manufacturing.
The CSW-50 is part of McFlusion's distributed (decentralized) CIP/SIP concept, bringing CIP and SIP operations closer to the point of use. This approach reduces system complexity while improving process performance, operational efficiency, and validation (regulatory) compliance.
Key advantages include:
✔ Superior CIP/SIP Performance – Reliable delivery of validated cleaning and sterilization parameters for effective residue removal and microbial control.
✔ Enhanced Process Flexibility – Supports multiple process equipment, reducing turnaround times and improving manufacturing efficiency.
✔ Optimized Utility Utilization – Minimizes piping runs, reduces utility consumption, and improves overall system efficiency.
✔ Improved Sterility Assurance – Repeatable, documented cleaning and sterilization cycles support robust contamination control strategies.
✔ Enhanced GMP Compliance – Automated, reproducible CIP/SIP sequences with comprehensive process monitoring support validation and audit readiness.
Designed for sterile and parenteral drug manufacturing, the CSW-50 delivers the performance, flexibility, and compliance required for modern aseptic processing.